229 related articles for article (PubMed ID: 15905361)
1. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells.
Du H; Daftary GS; Lalwani SI; Taylor HS
Mol Endocrinol; 2005 Sep; 19(9):2222-33. PubMed ID: 15905361
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
3. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter.
Peng L; Malloy PJ; Feldman D
Mol Endocrinol; 2004 May; 18(5):1109-19. PubMed ID: 14963110
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
5. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1).
Song CS; Echchgadda I; Seo YK; Oh T; Kim S; Kim SA; Cho S; Shi L; Chatterjee B
Mol Endocrinol; 2006 Apr; 20(4):795-808. PubMed ID: 16357103
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human placental lactogen expression by 1,25-dihydroxyvitamin D3.
Stephanou A; Ross R; Handwerger S
Endocrinology; 1994 Dec; 135(6):2651-6. PubMed ID: 7988455
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 up-regulates expression of hsa-let-7a-2 through the interaction of VDR/VDRE in human lung cancer A549 cells.
Guan H; Liu C; Chen Z; Wang L; Li C; Zhao J; Yu Y; Zhang P; Chen W; Jiang A
Gene; 2013 Jun; 522(2):142-6. PubMed ID: 23566834
[TBL] [Abstract][Full Text] [Related]
8. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes.
Wang TT; Tavera-Mendoza LE; Laperriere D; Libby E; MacLeod NB; Nagai Y; Bourdeau V; Konstorum A; Lallemant B; Zhang R; Mader S; White JH
Mol Endocrinol; 2005 Nov; 19(11):2685-95. PubMed ID: 16002434
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of vitamin D responsive elements in normal and transformed keratinocytes.
Xie Z; Bikle DD
J Invest Dermatol; 1998 May; 110(5):730-3. PubMed ID: 9579536
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 up-regulates TLR10 while down-regulating TLR2, 4, and 5 in human monocyte THP-1.
Verma R; Jung JH; Kim JY
J Steroid Biochem Mol Biol; 2014 May; 141():1-6. PubMed ID: 24373795
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a putative vitamin D response element in the avian calcium binding protein gene.
Macdonald PN; Whitfield GK; Haussler CA; Hocker AM; Haussler MR; Komm BS
DNA Cell Biol; 1992 Jun; 11(5):377-83. PubMed ID: 1318720
[TBL] [Abstract][Full Text] [Related]
12. Direct regulation of beta3-integrin subunit gene expression by HOXA10 in endometrial cells.
Daftary GS; Troy PJ; Bagot CN; Young SL; Taylor HS
Mol Endocrinol; 2002 Mar; 16(3):571-9. PubMed ID: 11875117
[TBL] [Abstract][Full Text] [Related]
13. A differential screen for ligand-regulated genes: identification of HoxA10 as a target of vitamin D3 induction in myeloid leukemic cells.
Rots NY; Liu M; Anderson EC; Freedman LP
Mol Cell Biol; 1998 Apr; 18(4):1911-8. PubMed ID: 9528762
[TBL] [Abstract][Full Text] [Related]
14. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
15. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
17. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts.
Veenstra TD; Fahnestock M; Kumar R
Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335
[TBL] [Abstract][Full Text] [Related]
18. EMX2 gene expression in the female reproductive tract and aberrant expression in the endometrium of patients with endometriosis.
Daftary GS; Taylor HS
J Clin Endocrinol Metab; 2004 May; 89(5):2390-6. PubMed ID: 15126568
[TBL] [Abstract][Full Text] [Related]
19. The expression of RNA helicase DDX5 is transcriptionally upregulated by calcitriol through a vitamin D response element in the proximal promoter in SiHa cervical cells.
González-Duarte RJ; Cázares-Ordoñez V; Díaz L; Ortíz V; Larrea F; Avila E
Mol Cell Biochem; 2015 Dec; 410(1-2):65-73. PubMed ID: 26314252
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter.
Kitazawa R; Kitazawa S
Biochem Biophys Res Commun; 2002 Jan; 290(2):650-5. PubMed ID: 11785948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
